The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-8726
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK ; volume:34 ; number:12 ; day:20 ; month:4 ; year:2016 ; pages:1601-1609 ; date:12.2016
World journal of urology ; 34, Heft 12 (20.4.2016), 1601-1609, 12.2016
- Urheber
-
Rosario, Derek J.
- Beteiligte Personen und Organisationen
-
Davey, Patrick
Green, James
Greene, Damien
Turner, Bruce
Payne, Heather
Kirby, Mike
SpringerLink (Online service)
- DOI
-
10.1007/s00345-016-1818-2
- URN
-
urn:nbn:de:1111-2016120810933
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rosario, Derek J.
- Davey, Patrick
- Green, James
- Greene, Damien
- Turner, Bruce
- Payne, Heather
- Kirby, Mike
- SpringerLink (Online service)
Ähnliche Objekte (12)
Luteinizing hormone-releasing hormone antagonists
Growth hormone – releasing hormone in the immune system
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
Thyreotropin-Releasing-Hormon (TRH)
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer: A systematic review with meta-analysis
Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis
Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report
Untersuchungen über Wachstumshormon-Releasing-Hormon: Plasmaspiegel bei Akromegalie und Interaktionen mit Thyreotropin-Releasing-Hormon
Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study
Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly
Luteinizing hormone-releasing hormone antagonists
Growth hormone – releasing hormone in the immune system
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
Thyreotropin-Releasing-Hormon (TRH)
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer: A systematic review with meta-analysis
Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis
Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report
Untersuchungen über Wachstumshormon-Releasing-Hormon: Plasmaspiegel bei Akromegalie und Interaktionen mit Thyreotropin-Releasing-Hormon
Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study
Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly
Luteinizing hormone-releasing hormone antagonists
Growth hormone – releasing hormone in the immune system
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
Thyreotropin-Releasing-Hormon (TRH)
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer: A systematic review with meta-analysis
Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis
Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report
Untersuchungen über Wachstumshormon-Releasing-Hormon: Plasmaspiegel bei Akromegalie und Interaktionen mit Thyreotropin-Releasing-Hormon
Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study